Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › San Francisco › NPI 1689772592
Hospital

University of California, San Francisco

University of California, San Francisco was paid $20.99M by Medicaid between Jan 2018 and Nov 2024, across 245 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 24% of everything it billed.

33Billing provider infoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
SAN FRANCISCO, CA 94143
33aNPI1689772592assigned 09/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.99M
24GClaims273,981
24DCodes billed245
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#119 of 410
Median peer was paid$6.90M
This provider vs. median3.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201846,449$1.05M
201945,837$882K
202025,562$1.53M
202131,850$2.72M
202234,519$3.29M
202352,884$6.38M
2024incomplete36,880$5.13M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 24% 75,554 63,648 $5.04M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 10,987 9,546 $2.45M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4.9% 2,021 2,009 $1.02M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4.3% 2,645 1,881 $897K
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 3.3% 369 89 $697K
78815 Positron emission tomography (PET) for limited area imaging 3.2% 328 325 $672K
71260 Computed tomography, thorax, diagnostic; with contrast material 3.0% 2,012 1,989 $631K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 2.8% 1,418 1,402 $578K
Q3014 Telehealth originating site facility fee 2.6% 22,139 18,993 $545K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 2.6% 1,232 1,167 $537K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.3% 2,542 1,880 $488K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.8% 3,069 2,745 $381K
233 more codes
36415 Collection of venous blood by venipuncture 1.6% 2,648 $344K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 1.4% 2,841 $291K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.3% 114 $283K
77080 1.3% 1,033 $272K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 1,385 $249K
71250 1.1% 1,496 $228K
99285 Emergency room visit (most serious) 1.0% 1,157 $218K
77067 Screening mammography, bilateral, including computer-aided detection 1.0% 1,073 $213K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 5,240 $204K
96375 Therapeutic injection; each additional sequential IV push <1% 2,162 $196K
80053 Comprehensive metabolic panel <1% 5,796 $185K
78812 <1% 66 $175K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,670 $166K
80048 Basic metabolic panel (calcium, ionized) <1% 3,202 $152K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,811 $148K
71046 Radiologic examination, chest; 2 views <1% 3,007 $144K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 4,941 $137K
J0485 Injection, belatacept, 1 mg <1% 131 $111K
74183 <1% 211 $104K
90677 <1% 238 $103K
93296 <1% 2,831 $103K
78431 <1% 27 $98K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 722 $97K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 1,440 $94K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 965 $91K
77386 <1% 98 $88K
72197 <1% 104 $83K
67028 Intravitreal injection of a pharmacologic agent <1% 637 $80K
77300 <1% 143 $78K
77373 <1% 46 $78K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 8,982 $73K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 174 $72K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,142 $67K
92557 <1% 246 $51K
77336 <1% 289 $50K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 138 $49K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 487 $48K
77301 <1% 30 $48K
76770 <1% 258 $48K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 515 $47K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,853 $46K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,886 $45K
90662 <1% 1,745 $44K
70450 Computed tomography, head or brain; without contrast material <1% 351 $44K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,427 $44K
0760 <1% 550 $42K
J0178 Injection, aflibercept, 1 mg <1% 105 $42K
93975 <1% 141 $41K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 4,236 $39K
83735 <1% 3,290 $38K
82565 <1% 2,785 $37K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 401 $37K
93925 <1% 86 $35K
72141 <1% 63 $35K
71045 Radiologic examination, chest; single view <1% 519 $34K
94010 <1% 399 $32K
92083 <1% 578 $32K
91320 <1% 477 $32K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 144 $31K
83880 <1% 453 $30K
76536 <1% 168 $28K
84443 Thyroid stimulating hormone (TSH) <1% 1,533 $27K
77334 <1% 29 $27K
97535 Self-care/home management training, each 15 minutes <1% 497 $26K
82947 <1% 2,469 $26K
96361 Intravenous infusion, hydration; each additional hour <1% 459 $26K
77063 Screening digital breast tomosynthesis, bilateral <1% 366 $23K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 123 $22K
96415 <1% 309 $20K
96402 <1% 226 $19K
70551 Magnetic resonance imaging, brain; without contrast material <1% 51 $19K
93971 <1% 87 $18K
86900 <1% 1,348 $16K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 522 $15K
93880 <1% 42 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 520 $14K
85027 <1% 1,964 $14K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 422 $14K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 64 $14K
77338 <1% 31 $14K
93970 <1% 40 $13K
84100 <1% 2,369 $13K
82728 <1% 222 $12K
J3490 Unclassified drugs <1% 1,287 $12K
80051 <1% 1,094 $12K
83036 Hemoglobin; glycosylated (A1C) <1% 1,102 $11K
84466 <1% 136 $11K
93280 <1% 158 $11K
84460 <1% 1,617 $10K
84450 <1% 1,540 $10K
80061 Lipid panel <1% 663 $10K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 13 $10K
80197 <1% 330 $10K
81001 <1% 2,095 $9K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 540 $9K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 498 $9K
82247 <1% 1,356 $9K
72082 <1% 219 $9K
86901 <1% 1,266 $9K
77066 Tomosynthesis, mammo <1% 37 $8K
0510 <1% 301 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 405 $8K
87340 <1% 628 $8K
84439 <1% 618 $8K
85610 <1% 2,341 $8K
84075 <1% 1,272 $8K
72100 <1% 79 $7K
87088 <1% 827 $7K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,912 $7K
82803 <1% 762 $7K
82040 <1% 1,140 $7K
82570 <1% 973 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 96 $6K
0272 <1% 89 $6K
86803 <1% 494 $6K
70491 <1% 13 $6K
76830 Ultrasound, transvaginal <1% 28 $6K
83540 <1% 157 $6K
0450 Emergency room services <1% 82 $6K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 224 $6K
86317 <1% 551 $6K
73502 <1% 93 $5K
86850 <1% 495 $5K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 141 $5K
82962 <1% 721 $5K
86704 <1% 434 $5K
99215 Doctor's office visit, returning patient (complex) <1% 27 $5K
92134 <1% 1,574 $5K
84295 <1% 328 $5K
87077 <1% 245 $5K
86665 <1% 129 $5K
76882 <1% 25 $4K
71275 Computed tomographic angiography, chest, with contrast material <1% 12 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 593 $4K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 99 $4K
84520 <1% 539 $4K
87186 <1% 180 $4K
90686 <1% 489 $4K
84156 <1% 467 $3K
92133 <1% 383 $3K
81003 <1% 1,147 $3K
82274 <1% 235 $3K
73564 <1% 26 $3K
74230 <1% 14 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 79 $3K
86592 <1% 415 $3K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 27 $3K
86140 <1% 670 $3K
84132 <1% 315 $3K
73630 <1% 53 $3K
97116 <1% 65 $3K
96417 <1% 18 $2K
73130 <1% 51 $2K
83605 <1% 731 $2K
86644 <1% 168 $2K
86664 <1% 125 $2K
83615 <1% 439 $2K
90732 <1% 40 $2K
87799 <1% 44 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 15 $2K
82784 <1% 176 $2K
73562 <1% 41 $2K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 27 $2K
73030 <1% 25 $2K
82607 <1% 62 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 146 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 845 $1K
85651 <1% 553 $1K
77073 <1% 88 $1K
82310 <1% 183 $1K
84484 <1% 708 $1K
93922 <1% 12 $1K
0761 <1% 29 $1K
93246 <1% 13 $1K
97750 <1% 13 $1K
90656 <1% 102 $997.70
99001 <1% 14 $985.88
86777 <1% 68 $977.18
82043 <1% 101 $947.22
87631 <1% 14 $889.93
87070 <1% 53 $867.57
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 45 $865.28
86780 <1% 106 $847.31
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 17 $816.86
J2704 Injection, propofol, 10 mg <1% 75 $766.03
93325 <1% 14 $716.26
85730 <1% 130 $709.00
87497 <1% 56 $689.14
84600 <1% 87 $684.23
83690 <1% 461 $665.61
73610 <1% 12 $642.94
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 110 $596.84
20610 <1% 13 $563.29
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 39 $557.06
85018 <1% 907 $522.49
92250 <1% 28 $507.27
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 39 $480.82
82746 <1% 12 $412.71
86787 <1% 27 $371.05
G0008 Administration of influenza virus vaccine <1% 153 $347.43
J3010 Injection, fentanyl citrate, 0.1 mg <1% 181 $327.86
88112 <1% 107 $254.86
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) <1% 168 $227.73
93299 <1% 12 $226.25
82435 <1% 21 $199.28
82374 <1% 19 $197.04
94760 <1% 39 $144.83
87205 <1% 53 $141.75
99221 <1% 49 $135.04
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size <1% 195 $107.38
J1644 Injection, heparin sodium, per 1000 units <1% 36 $107.01
87081 <1% 12 $105.32
94729 <1% 12 $96.46
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 44 $92.19
17311 <1% 16 $69.68
84481 <1% 15 $66.03
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study <1% 59 $53.81
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 31 $48.41
87040 <1% 32 $47.11
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 33 $46.15
J7060 5% dextrose/water (500 ml = 1 unit) <1% 233 $45.37
51798 <1% 12 $20.11
T1014 Telehealth transmission, per minute, professional services bill separately <1% 19 $16.20
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 15 $15.05
81002 <1% 12 $10.60
82977 <1% 20 $6.46
J7120 Ringers lactate infusion, up to 1000 cc <1% 12 $0.05
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 48 $0.04
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 14 $0.00
99199 Unlisted special service, procedure or report 0% 16 $0.00
36416 0% 60 $0.00
90480 0% 14 $0.00
82550 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGUNASEKARAN, SURESH (PRESIDENT & CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under GUNASEKARAN, SURESH

Full network →
ProviderLocationPaid
University of California San Francisco Medical CenterSan Francisco, CA$54.08M
University of California San FranciscoSan Francisco, CA$1.78M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.